The AfterRaise week
81 rounds, $10.5B of announced capital. The largest: Nscale raised $3.4B. Sorted by size; every figure links to its source.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations, development efforts and its business reach.
The company said the funding supports support its capacity expansion in the United States, Taiwan, and the rest of APAC, expand its inference services, and support strategic hiring.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports scale its agentic security platform, as well as its research, training, and go-to-market efforts.
The company said the funding supports increase its flight cadence, deepen its pharmaceutical partnerships, and move closer to delivering the first medicine made in space.
The company said the funding supports complete the development of its 100 MW / 400 MWh White Tank battery energy storage facility in Arizona.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate the scaling of Palette Neat, an agentic software environment for Physical AI, and next-generation hardware that will deliver 1,000 dense TOPS of compute in purpose-built Physical AI silicon.
The company said the funding supports expand operations and its development efforts.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand operations and its development efforts.
The announcement did not set out what the funding supports.
The company said the funding supports advance the clinical development of its lead program, elismetrep, a novel, oral TRPM8 channel blocker currently in Phase 3 trials for the acute treatment of migraine.
The company said the funding supports support the development and commercialization of A-1 and its photonic memory architecture, and expand its engineering team.
The company said the funding supports fully fund the advancement of its lead candidate, AC01, through Phase 2b clinical development (GOAL-HF2 trial) in patients with chronic advanced heart failure with reduced ejection fraction (HFrEF), with the goal of establishing a Phase 3-ready asset by 2028.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports bring fillmore (its autonomous recruiting coworker) to general availability, expand the team from 80 to 250 people by the end of next year, open a New York office, and double down on its 10x Recruiting community and training program.
The company said the funding supports expansion across sales, partnerships, channels and customer support.
The company said the funding supports accelerate its manufacturing capabilities and expand global deployment of its SkyDome Family of Systems.
The company said the funding supports expand its review, branching, and evaluation capabilities, and grow its engineering team across AI and systems engineering Led by Founder and CEO Pari Singh, Flow Engineering builds an agentic systems engineering platform that allows hardware teams to design, build, and iterate on physical products.
The company said the funding supports advance both of its platforms, including IND-enabling studies that advance to first-in-human trials in autoimmune disease.
The company said the funding supports advance its pipeline of disease-modifying investigational RNA therapeutics, including its lead candidate, CAP1-FMR1 for Fragile X Syndrome.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports support the launch of its open beta platform and continue developing its privacy-by-architecture networking infrastructure for individuals, enterprises, and their agents.
The company said the funding supports accelerate software and AI platform capabilities, worker safety solutions, enterprise system integrations, frontline hardware, and expansion across industrial and hospitality markets.
The announcement did not set out what the funding supports.
The company said the funding supports advance clinical research and interventional studies, expand its healthcare practitioner education, scale Powered by Tiny, its B2B platform, accelerate TinyAI, an AI trained on its proprietary dataset of nearly 200,000 microbiome profiles, to deliver personalized, science-backed guidance tied directly to a user's results.
The announcement did not set out what the funding supports.
The company said the funding supports move into more channels and markets, and fuel the expansion of its product offering.
The company said the funding supports deepen its research engine, build personalization capabilities, and grow the team across engineering, go-to-market, operations, and customer experience.
The company said the funding supports support continued product development and expansion in the United States.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.